SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
92 hedge funds and large institutions have $62.4M invested in Sorrento Therapeutics, Inc. in 2020 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 39 increasing their positions, 16 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
42% less capital invested
Capital invested by funds: $107M → $62.4M (-$44.8M)
Holders
92
Holding in Top 10
–
Calls
$2.28M
Puts
$1.32M
Top Buyers
| 1 | +$1.84M | |
| 2 | +$1.49M | |
| 3 | +$736K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$479K |
| 5 |
JPMorgan Chase & Co
New York
|
+$441K |
Top Sellers
| 1 | -$1.51M | |
| 2 | -$688K | |
| 3 | -$669K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$459K |
| 5 |
HF
HRT Financial
New York
|
-$364K |